Oramed Pharmaceuticals (ORMP) Other Non Operating Income (2011 - 2026)
Oramed Pharmaceuticals (ORMP) posted Other Non Operating Income of -$50000.0 for Q1 2026, up 99.87% on a QoQ basis from -$39.2 million in Q4 2025, and down 119.31% year-over-year from $259000.0 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Other Non Operating Income (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Other Non Operating Income history runs 12 years deep, the most recent figure standing at -$50000.0 for Q1 2026.
- Quarterly Other Non Operating Income fell 119.31% year-over-year to -$50000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 434.06% YoY) and the FY2025 annual result came in at -$606000.0, down 2144.44% from the prior year.
- Other Non Operating Income was -$50000.0 for Q1 2026 at Oramed Pharmaceuticals, up from -$39.2 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $32.3 million in Q3 2025 and bottomed at -$39.2 million in Q4 2025.
- A 3-year average of $290875.0 and a median of $1.9 million in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2025 — Other Non Operating Income soared 93.92% — and 2026, when it tumbled 119.31%.
- Oramed Pharmaceuticals' Other Non Operating Income stood at -$20.1 million in 2024, then tumbled by 94.97% to -$39.2 million in 2025, then jumped by 99.87% to -$50000.0 in 2026.
- Business Quant data shows ORMP's Other Non Operating Income at -$50000.0 in Q1 2026, -$39.2 million in Q4 2025, and $32.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50,000.00 |
| Dec 31, 2025 | -39.17 Mn |
| Sep 30, 2025 | 32.28 Mn |
| Jun 30, 2025 | 8.90 Mn |
| Mar 31, 2025 | 259,000.00 |
| Dec 31, 2024 | -20.09 Mn |
| Sep 30, 2024 | 16.65 Mn |
| Mar 31, 2024 | 3.55 Mn |
| Nov 30, 2019 | 209,000.00 |
| Aug 31, 2019 | 239,000.00 |
| May 31, 2019 | 263,000.00 |
| Feb 28, 2019 | 273,000.00 |
| Nov 30, 2018 | 286,000.00 |
| Aug 31, 2018 | 255,000.00 |
| May 31, 2018 | 209,000.00 |
| Feb 28, 2018 | 217,000.00 |
| Nov 30, 2017 | 222,000.00 |
| Aug 31, 2017 | -592,000.00 |
| May 31, 2017 | 210,000.00 |
| Feb 28, 2017 | 203,000.00 |